how to get off of tirzepatide Out Your System: Clearance Timeline Tirzepatide Peptide: How It Works

Once-monthly maridebart cafraglutide for the treatment of obesity - A phase 2 trial

Mounjaro was approved for type 2 diabetes in May 2022, while Zepbound was approved for chronic weight management in November 2023

Results from the SURMOUNT-1 study showed that individuals who used tirzepatide lost an average of 20.9% of their body weight at 72 weeks

Stay hydrated: Drinking enough water supports overall health and can help with appetite control

More reliable contraception options while on GLP-1s: IUDs (hormonal or copper) have excellent reliability on GLP-1s and are the most dependable option since theyre not affected by GLP-1s at all